18 research outputs found

    Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.

    Get PDF
    To explore possible correlations among brain lesion location, development of psychiatric symptoms and the use of antiepileptic drugs (AEDs) in a population of patients with brain tumor and epilepsy. The medical records of 283 patients with various types of brain tumor (161 M/122 F, mean age 64.9 years) were analysed retrospectively. Patients with grade III and IV glioma, previous history of epileptic seizures and/or psychiatric disorders were excluded. Psychiatric symptoms occurring after initiation of AED therapy were considered as treatment emergent psychiatric adverse events (TE-PAEs) if they fulfilled the following conditions: (1) onset within 4 weeks after the beginning of AED therapy; (2) disappearance on drug discontinuation; (3) absence of any other identified possible concurrent cause. The possible influence of the following variables were analysed: (a) AED drug and dose; (b) location and neuroradiologic features of the tumor, (c) location and type of EEG epileptic abnormalities, (d) tumor excision already or not yet performed; (e) initiation or not of radiotherapy. TE-PAEs occurred in 27 of the 175 AED-treated patients (15.4%). Multivariate analysis showed a significant association of TE-PAEs occurrence with location of the tumor in the frontal lobe (Odds ratio: 5.56; 95% confidence interval 1.95-15.82; p value: 0.005) and treatment with levetiracetam (Odds ratio: 3.61; 95% confidence interval 1.48-8.2; p value: 0.001). Drug-unrelated acute psychiatric symptoms were observed in 4 of the 108 AED-untreated patients (3.7%) and in 7 of the 175 AED-treated patients (4%). The results of the present study suggest that an AED alternative to levetiracetam should be chosen to treat epileptic seizures in patients with a brain tumor located in the frontal lobe to minimize the possible onset of TE-PAEs

    Exploring the gaps between education and pharmacy practice on antimicrobial stewardship: a qualitative study among pharmacists in Qatar [Corrigendum]

    No full text
    Nasr ZG, Higazy A, Wilbur K. Adv Med Educ Pract. 2019:10:287–295.   The authors have advised that an additional funding statement should have been included in the “Acknowledgments” section of their paper (page 293). The authors apologize for this error and confirm that the additional funding source does not constitute a conflict of interest in this work, nor affect the work in any way. The corrected details are as follows:   Acknowledgments This study was completed with funding from an Internal Student Grant from Qatar University. The publication of this article was funded by the Qatar National Library. The abstract of this paper was presented at the 2018 ACCP Global Conference on Clinical Pharmacy as a poster presentation with interim findings. The poster’s abstract was published in “Poster Abstracts” in Journal of the American College of Clinical Pharmacy; DOI: 10.1002/JAC5.1059.   Read the original articl
    corecore